Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals share price today

(NASDAQ: CPRX)

Catalyst Pharmaceuticals share price is $22.87 & ₹1,975.97 as on 23 Jan 2025, 20.25 hrs IST

$22.87

-0.05

(-0.22%)

Market is closed - opens 8 PM, 23 Jan 2025

View live Catalyst Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Catalyst Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Catalyst Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Catalyst Pharmaceuticals share price movements

  • Today's Low: $22.65
    Today's High: $23.13

    Day's Volatility :2.08%

  • 52 Weeks Low: $13.12
    52 Weeks High: $24.27

    52 Weeks Volatility :45.96%

Catalyst Pharmaceuticals Returns

PeriodCatalyst Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
6.82%
-5.5%
0.0%
6 Months
31.66%
-4.3%
0.0%
1 Year
56.64%
1.6%
0.0%
3 Years
304.78%
9.8%
-11.0%

Catalyst Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$22.87
Open
$22.92
Today's High
$22.51
Today's Low
$22.17
Market Capitalization
$2.7B
Today's Volume
$727.4K
52 Week High
$24.27
52 Week Low
$13.1161
Revenue TTM
$460.5M
EBITDA
$211.4M
Earnings Per Share (EPS)
$1.18
PE Ratio
19.38
Profit Margin
31.01%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
28.29%

How to invest in Catalyst Pharmaceuticals Stock (CPRX) from India?

It is very easy for Indian residents to invest directly in Catalyst Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Catalyst Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Catalyst Pharmaceuticals or CPRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Catalyst Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Catalyst Pharmaceuticals shares which would translate to 0.038 fractional shares of Catalyst Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Catalyst Pharmaceuticals, in just a few clicks!

Returns in Catalyst Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Catalyst Pharmaceuticals investment value today

Current value as on today

₹1,60,590

Returns

₹60,590

(+60.59%)

Returns from Catalyst Pharmaceuticals Stock

₹56,644 (+56.64%)

Dollar Returns

₹3,946 (+3.95%)

Indian investors sentiment towards Catalyst Pharmaceuticals

115.79%

Period: Oct 24, 2024 to Jan 22, 2025. Change in 30 Days versus previous period

Investment in Catalyst Pharmaceuticals from India has grown in the last 30 days as on Jan 23, 2025. 115.79% more purchase transactions for Catalyst Pharmaceuticals in the last 30 days versus the previous period.

0%

Period: Oct 24, 2024 to Jan 22, 2025. Change in 30 Days versus previous period

Search volume for Catalyst Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Jan 23, 2025. 0% more investors are searching Catalyst Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Catalyst Pharmaceuticals

  • BlackRock Inc

    15.94%

  • Vanguard Group Inc

    6.74%

  • Deerfield Management Co

    5.22%

  • State Street Corp

    4.77%

  • Dimensional Fund Advisors, Inc.

    2.53%

  • Pacer Advisors, INC.

    2.35%

Analyst Recommendation on Catalyst Pharmaceuticals

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Catalyst Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Catalyst Pharmaceuticals

What analysts predicted

Upside of 44.29%

Target:

$33.00

Current:

$22.87

Insights on Catalyst Pharmaceuticals

  • Price Movement

    In the last 3 years, CPRX stock has moved up by 312.8%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 98.50M → 128.69M (in $), with an average increase of 12.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 23.27M → 43.88M (in $), with an average increase of 25.0% per quarter

Catalyst Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Catalyst Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Catalyst Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Catalyst Pharmaceuticals Inc logo
5.78%
31.66%
56.64%
304.78%
471.75%
Biontech Se logo
0.91%
36.01%
16.45%
-23.72%
246.9%
Regeneron Pharmaceuticals, Inc. logo
-4.82%
-36.1%
-28.29%
9.42%
100.35%
Vertex Pharmaceuticals Incorporated logo
4.86%
-13.05%
0.1%
86.35%
88.24%
Alnylam Pharmaceuticals, Inc. logo
9.57%
12.05%
43.92%
95.22%
127.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Catalyst Pharmaceuticals Inc logo
19.38
19.38
0.0
2.06
0.28
0.18
NA
5.54
Biontech Se logo
160.8
NA
0.04
-3.33
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.02
17.02
1.05
44.99
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.1
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Catalyst Pharmaceuticals Inc logo
Buy
$2.7B
471.75%
19.38
31.01%
Biontech Se logo
Buy
$28.1B
246.9%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$75.6B
100.35%
17.02
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$110.2B
88.24%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$34.2B
127.75%
NA
-15.86%

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.
Organization
Catalyst Pharmaceuticals
Employees
167
CEO
Mr. Richard John Daly M.B.A.
Industry
Health Technology

Management People of Catalyst Pharmaceuticals

NameTitle
Mr. Richard John Daly M.B.A.
President, CEO & Director
Dr. Steven R. Miller Ph.D.
Executive VP, COO & Chief Scientific Officer
Dr. Gary Ingenito M.D., Ph.D.
Chief Medical & Regulatory Officer
Mr. Jeffrey Del Carmen
Executive VP & Chief Commercial Officer
Mr. Michael W. Kalb CPA
Executive VP, Treasurer & CFO
Ms. Mary Coleman
VP & Head of Investor Relations
Mr. Brian Elsbernd J.D.
Chief Compliance Officer & Chief Legal Officer
Mr. Pete Curry Sr.
Vice President of Sales
Dr. Stanley Iyadurai M.D., Ph.D.
Senior Vice President of Medical Affairs & Drug Discovery
Dr. Preethi Sundaram Ph.D.
Chief Strategy Officer

Important FAQs about investing in Catalyst Pharmaceuticals (CPRX) from India :

What is Catalyst Pharmaceuticals share price today?

Catalyst Pharmaceuticals share price today stands at $22.87, Open: $22.92 ; Previous Close: $22.92 ; High: $23.13 ; Low: $22.65 ; 52 Week High: $24.27 ; 52 Week Low: $13.12. The stock opens at $22.92, after a previous close of $22.92. The stock reached a daily high of $23.13 and a low of $22.65, with a 52-week high of $24.27 and a 52-week low of $13.12.

Can Indians buy Catalyst Pharmaceuticals shares?

Yes, Indians can invest in the Catalyst Pharmaceuticals (CPRX) from India.

With INDmoney, you can buy Catalyst Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Catalyst Pharmaceuticals at zero transaction cost.

How can I buy Catalyst Pharmaceuticals shares from India?

It is very easy to buy Catalyst Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Catalyst Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Catalyst Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Catalyst Pharmaceuticals stocks?

To start investing in Catalyst Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Catalyst Pharmaceuticals

Today’s highest price of Catalyst Pharmaceuticals (CPRX) is $23.13.

Today’s lowest price of Catalyst Pharmaceuticals (CPRX) is $22.65.

What is today's market capitalisation of Catalyst Pharmaceuticals

Today's market capitalisation of Catalyst Pharmaceuticals CPRX is 2.7B

What is the 52 Week High and Low Range of Catalyst Pharmaceuticals

  • 52 Week High

    $24.27

  • 52 Week Low

    $13.12

What are the historical returns of Catalyst Pharmaceuticals?

  • 1 Month Returns

    5.78%

  • 3 Months Returns

    31.66%

  • 1 Year Returns

    56.64%

  • 5 Years Returns

    471.75%

Who is the Chief Executive Officer (CEO) of Catalyst Pharmaceuticals

Mr. Richard John Daly M.B.A. is the current Chief Executive Officer (CEO) of Catalyst Pharmaceuticals.